Article
Estimating the serological underrecognition of patients with weak or partial RHD variants.
Transfusion - 1 May 2024
Ramsey Glenn, Barriteau Christina M
Abstract excerpt
BACKGROUND: For patients with weak or discrepant RhD RBC phenotypes, RHD genotyping is employed to determine need for RhD-negative management. However, many RHD variants are type D-negative or D-positive. Serological recognition rates (RRs) of weak and partial RHD variants are poorly characterized. STUDY DESIGN AND METHODS: Four US studies employing RHD genotyping for weak or discrepant RhD phenotypes provided...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
